Novel Cell Therapy Approaches for Oncology Highlight Manufacturing and Commercialization Strategies at Cell | Filippo Petti, CEO, Celyad Oncology SA. 00:10:00

Share On Facebook Share On Twitter

Filippo Petti, CEO/CFO of Celyad Oncology, reflects on the significance of robust manufacturing processes for delivering innovative therapeutics in solid tumor treatment, foreseeing their potential market impact akin to established biological therapies, in a discussion at the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.

Recent Videos